View Item 

Show simple item record

A new alloantigen, Ly-8, recognized by C3H anti-AKR serum
dc.contributor.authorMurphy, Donal B.en_US
dc.contributor.authorFrelinger, Jeffrey A.en_US
dc.date.accessioned2006-09-11T18:09:19Z
dc.date.available2006-09-11T18:09:19Z
dc.date.issued1976-12en_US
dc.identifier.citationFrelinger, Jeffrey A.; Murphy, Donal B.; (1976). "A new alloantigen, Ly-8, recognized by C3H anti-AKR serum." Immunogenetics 3(1): 481-487. <http://hdl.handle.net/2027.42/46747>en_US
dc.identifier.issn0093-7711en_US
dc.identifier.issn1432-1211en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46747
dc.description.abstractA new membrane alloantigen, designated Ly-8.2, is defined by a C3H anti-AKR serum. The locus, Ly-8 , which controls this determinant is not linked to Thy-1, Ly-4, Ly-6, H-2 , albino (c), or brown ( b ). Ly-8.2 has a unique strain distribution, and appears to be present on both T and B lymphocytes.en_US
dc.format.extent352313 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlag; Springer-Verlag New York Inc.en_US
dc.subject.otherBiomedicineen_US
dc.subject.otherAllergologyen_US
dc.subject.otherImmunologyen_US
dc.subject.otherCell Biologyen_US
dc.titleA new alloantigen, Ly-8, recognized by C3H anti-AKR serumen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Microbiology, University of Southern California Medical School, 90033, Los Angeles, California; Division of Immunology, Department of Medicine, Stanford Medical School, 94305, Stanford, California; Department of Human Genetics, University of Michigan School, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Microbiology, University of Southern California Medical School, 90033, Los Angeles, California; Division of Immunology, Department of Medicine, Stanford Medical School, 94305, Stanford, California; Department of Human Genetics, University of Michigan School, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46747/1/251_2005_Article_BF01576977.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF01576977en_US
dc.identifier.sourceImmunogeneticsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
251_2005_Article_BF01576977.pdf
Size:
344.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.